Veteran Pharma Insider Buys: Biotech Stock Momentum Explored
A seasoned pharma investor places a sizable bet on Nuvation Bio as a promising drug moves forward. Learn how insider ...
Discover the importance of using asset allocation to balance risk and return. This strategy can enhance your investment performance.
28,462 articlesA seasoned pharma investor places a sizable bet on Nuvation Bio as a promising drug moves forward. Learn how insider ...
When a Dentsply Sirona director buys a large block of shares, investors take notice. This article breaks down what th...
Nike has faced a decades-long love-hate relationship with investors: the brand remains powerful, but the stock has sl...
Freddie Mac data show mortgage rates jump highest in nearly a year, with the 30-year fixed at about 6.55% as buyers w...
A biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
When a company's top medical officer sells a large block and leaves with a zero direct stake, investors notice. This ...
A director sold 45,000 LUMN shares, triggering questions about Lumen Technologies stock sell signals. This article br...
Greg Abel’s early moves at Berkshire Hathaway signal a new investment ethos. This analysis breaks down the rationale,...
RLJ Lodging Trust has fallen about 8% over the last 12 months. Yet a sizeable stake by a key investor suggests there ...
Active ETFs are reshaping how people think about investing. This article explains what they are, when they can beat p...
February brought a sharp drop for Upstart as investors weighed margins, product risk, and leadership changes. This de...
A sweeping market update is arriving just as tech stocks face a new mix of opportunities and risks. This arguably mos...